Purchases and Sales Made in Q1 2021 in Celyad Oncology Sa (CYAD)
This table provides information about the institutional ownership of Celyad Oncology Sa (CYAD) during Q1 2021. The information is specifically focused on institutions that hold shares of Celyad Oncology SA.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 12, 2021
Q1 2021
|
Ubs Group Ag
|
BUY
|
- |
1.39K+ 278.4% |
$9.74K - $12.2K
|
1.89K
$984
|
|
|
May 13, 2021
Q1 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Apr 30, 2021
Q1 2021
|
Inspire Advisors, LLC
Meridian, ID |
SELL
|
- |
-53Closed |
$371 - $464
|
0
$0
|
|
|
May 13, 2021
Q1 2021
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-1.94K- 23.46% |
$13.6K - $17K
|
6.34K
$3.3K
|
|
|
May 04, 2021
Q1 2021
|
Victory Capital Management Inc
|
SELL
|
- |
-40.9K- 5.17% |
$286K - $358K
|
750K
$390K
|